mefloquine has been researched along with diazepam in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bergqvist, Y; Breyer, S; Burgmann, H; Feistauer, S; Feucht, M; Graninger, W; Hellgren, U; Uhl, F; Winkler, S | 1 |
Chung, L; Moore, SD | 1 |
1 review(s) available for mefloquine and diazepam
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for mefloquine and diazepam
Article | Year |
---|---|
[Mefloquine and sulfadoxine/pyrimethamine overdose in malaria tropica].
Topics: Adult; Diazepam; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Haloperidol; Humans; Malaria, Falciparum; Male; Mefloquine; Psychoses, Substance-Induced; Pyrimethamine; Sulfadoxine; Thioridazine | 1993 |
Neuropeptides modulate compound postsynaptic potentials in basolateral amygdala.
Topics: Action Potentials; Amygdala; Animals; Anti-Anxiety Agents; Cations, Monovalent; Chlorides; Cholecystokinin; Corticotropin-Releasing Hormone; Diazepam; Gap Junctions; Homeostasis; Male; Mefloquine; Neuropeptide Y; Neuropeptides; Patch-Clamp Techniques; Periodicity; Potassium; Rats; Receptors, GABA; Receptors, Glutamate; Somatostatin; Synaptic Potentials | 2009 |